A detailed history of Capital Investment Counsel, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Investment Counsel, LLC holds 52,471 shares of ABBV stock, worth $9.15 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
52,471
Previous 51,602 1.68%
Holding current value
$9.15 Million
Previous $8.85 Billion 17.07%
% of portfolio
1.79%
Previous 1.74%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $142,376 - $173,217
869 Added 1.68%
52,471 $10.4 Billion
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $363,137 - $424,062
2,346 Added 4.76%
51,602 $8.85 Billion
Q1 2024

Aug 14, 2024

BUY
$159.82 - $182.1 $2.81 Million - $3.2 Million
17,555 Added 55.38%
49,256 $8.97 Billion
Q4 2023

Aug 14, 2024

BUY
$137.6 - $154.97 $4.36 Million - $4.91 Million
31,701 New
31,701 $4.91 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $308B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Investment Counsel, LLC Portfolio

Follow Capital Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Counsel, LLC with notifications on news.